ProductsBack/CD168 / RHAMM antibody [N1N2], N-term

CD168 / RHAMM antibody [N1N2], N-term

Name: CD168 / RHAMM antibody [N1N2], N-term
SKU: GTX121502_G10
Availability: BackOrder

GTX121502

ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Product group Antibodies

TargetHMMR

Overview

Supplier
GeneTex
Product Name
CD168 / RHAMM antibody [N1N2], N-term
Delivery Days Customer
9
Application Supplier Note
WB: 1:500-1:3000. IHC-P: 1:100-1:1000. IP: 1:100-1:500. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Applications
ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Certification
Research Use Only
Clonality
Polyclonal
Concentration
1 mg/ml
Conjugate
Unconjugated
Gene ID3161
Target name
HMMR
Target description
hyaluronan mediated motility receptor
Target synonyms
CD168, IHABP, RHAMM, hyaluronan mediated motility receptor, intracellular hyaluronic acid-binding protein, receptor for hyaluronan-mediated motility
Host
Rabbit
Isotype
IgG
Protein IDO75330
Protein Name
Hyaluronan mediated motility receptor
Scientific Description
The protein encoded by this gene is involved in cell motility. It is expressed in breast tissue and together with other proteins, it forms a complex with BRCA1 and BRCA2, thus is potentially associated with higher risk of breast cancer. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq]
Storage Instruction
-20°C or -80°C,2°C to 8°C
UNSPSC
12352203

Li J, Ji X, Wang H. Targeting Long Noncoding RNA HMMR-AS1 Suppresses and Radiosensitizes Glioblastoma. Neoplasia. 2018,20(5):456-466. doi: 10.1016/j.neo.2018.02.010
Read this paper
Li J, Zhou Y, Wang H, et al. COX-2/sEH dual inhibitor PTUPB suppresses glioblastoma growth by targeting epidermal growth factor receptor and hyaluronan mediated motility receptor. Oncotarget. 2017,8(50):87353-87363. doi: 10.18632/oncotarget.20928
Read this paper
Huang M, Ma X, Shi H, et al. FAM83D, a microtubule-associated protein, promotes tumor growth and progression of human gastric cancer. Oncotarget. 2017,8(43):74479-74493. doi: 10.18632/oncotarget.20157
Read this paper
Lee YL, Lin KL, Chuang SM, et al. Elucidating Mechanisms of Bladder Repair after Hyaluronan Instillation in Ketamine-Induced Ulcerative Cystitis in Animal Model. Am J Pathol. 2017,187(9):1945-1959. doi: 10.1016/j.ajpath.2017.06.004
Read this paper